OraSure Technologies, Inc.
(NASDAQ : OSUR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.20%98.950.6%$570.02m
ISRGIntuitive Surgical, Inc.
1.58%530.182.4%$404.86m
ABTAbbott Laboratories
0.42%84.680.8%$400.46m
TMOThermo Fisher Scientific Inc.
-0.22%292.141.0%$387.20m
BSXBoston Scientific Corporation
0.22%41.751.1%$322.84m
BDXBecton, Dickinson and Company
1.91%242.781.1%$296.58m
ALGNAlign Technology, Inc.
-0.27%296.036.3%$281.39m
EWEdwards Lifesciences Corporation
0.48%191.901.2%$231.53m
DXCMDexCom, Inc.
0.64%154.778.3%$208.44m
SYKStryker Corporation
0.81%202.121.3%$202.97m
BAXBaxter International Inc.
0.47%81.691.7%$184.15m
ABMDABIOMED, Inc.
-0.61%254.733.3%$161.17m
WATWaters Corporation
0.19%210.793.8%$119.55m
ZBHZimmer Biomet Holdings, Inc.
-0.40%118.891.7%$117.66m
TNDMTandem Diabetes Care, Inc.
1.58%68.014.0%$105.16m

Company Profile

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The DNAG segment manufactures and sells specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.